Skip to main content

Table 1 Clinicopathological Characteristics of the study cohort

From: Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection

Characteristics

Training cohort(n = 201)

Validation cohort(n = 68)

P Value

Gender

  

0.639

 Female

50 (24.9)

15 (22.1)

 

 Male

151 (75.1)

53 (77.9)

 

Age

62.7 ± 11.6

62.8 ± 11.9

0.956

KFI

  

0.257

  < 2

125 (62.19)

37 (54.41)

 

  ≥ 2

76 (37.81)

31 (45.59)

 

Smoking

  

0.679

 No

121 (60.2)

39 (57.35)

 

 Yes

80 (39.8)

29 (42.65)

 

pT

  

0.359

 T1

41 (20.4)

12 (17.65)

 

 T2

63 (31.34)

21 (30.88)

 

 T3

54 (26.87)

15 (22.06)

 

 T4

43 (21.39)

20 (29.41)

 

pN

  

0.259

 N0

31 (15.42)

9 (13.24)

 

 N1

53 (26.37)

14 (20.59)

 

 N2

110 (54.73)

40 (58.82)

 

 N3

7 (3.48)

5 (7.35)

 

AJCC Stage

  

0.544

 III

61 (30.3)

18 (26.5)

 

 IV

140 (69.7)

50 (73.5)

 

Perineural invasion

  

0.931

 No

120 (59.7)

41 (60.3)

 

 Yes

81 (40.3)

27 (39.7)

 

Tumor differentiation

  

0.640

 Well differentiated

87 (43.3)

25 (36.8)

 

 Moderately differentiated

51 (25.4)

19 (27.9)

 

 Poorly differentiated

63 (31.3)

24 (35.3)

 

Depth of tumor invasion

  

0.268

  < 20 mm

127 (63.2)

48 (70.6)

 

  ≥ 20 mm

74 (36.8)

20 (29.4)

 

Number of Positive Nodes

  

0.648

 0

84 (41.79)

31 (45.6)

 

 1–2

58 (28.86)

21 (30.9)

 

 3–4

34 (16.92)

9 (13.2)

 

  ≥ 5

25 (12.44)

7 (10.3)

 

Lymphovascular invasion (%)

  

0.189

 No

41 (20.4)

9 (13.24)

 

 Yes

160 (79.6)

59 (86.76)

 

Primary Tumor Site

  

0.570

 Tongue

69 (34.33)

21 (30.88)

 

 Floor of mouth

60 (29.85)

25 (36.76)

 

 Other

72 (35.82)

22 (32.35)

 

Extracapsular extension

  

0.537

 No

158 (78.61)

51 (75)

 

 Yes

43 (21.39)

17 (25)

 

Bone invasion

  

0.366

 No

119 (59.2)

36 (52.94)

 

 Yes

82 (40.8)

32 (47.06)

 

Safety Margins

  

0.408

  < 5 mm

45 (22.39)

12 (17.65)

 

  ≥ 5 mm

156 (77.61)

56 (82.35)

 

SII

  

0.580

  < 535.5

120 (59.7)

38 (55.88)

 

  ≥ 535.5

81 (40.3)

30 (44.12)

 

NLR

  

0.480

  < 2.8

125 (62.19)

39 (57.35)

 

  ≥ 2.8

76 (37.81)

29 (42.65)

 

PLR

  

0.761

  < 162.5

114 (56.72)

40 (58.82)

 

  ≥ 162.5

87 (43.28)

28 (41.18)

 
  1. Abbreviations: AJCC American Joint Committee on Cancer, KFI Kaplan-Feinstein index, NLR neutrophil-lymphocyte ratio, PLR platelet–lymphocyte ratio, SII systematic immune-inflammation index